ADLINE CHEM LAB LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.07 INR | -4.98% |
|
0.00% | -28.82% |
| 03-05 | Adline Chem Lab CFO Steps Down | MT |
| 03-05 | Adline Chem Lab Limited Announces CFO Changes | CI |
More news
| 1 day | -4.98% | ||
| Current month | -26.40% | ||
| 1 month | -30.07% | ||
| 3 months | -33.55% | ||
| 6 months | -16.98% | ||
| Current year | -28.82% |
1 month
19.07
25.91
Current year
19.0728.97
1 year
6.2428.97
3 years
4.7928.97
5 years
4.7528.97
10 years
4.7528.97
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 02-02 | |
Shivani Pathak
BRD | Director/Board Member | 28 | 02-02 |
Adline Chem Lab Limited, formerly Kamron Laboratories Limited, is an India-based pharmaceutical company. The Company is operating in one segment: pharmaceutical products. The Company's products for the domestic market include anti-infectives, bone health, gastroenterology care, hemostatic, multi-vitamins, pediatric care, pain and inflammation, pregnancy and reproductive care, respiratory care and hepatocare. The Company's products for the international market include tablets, capsules and injections. The Company's veterinary products include B Complex Liver Extract With Vitamin B12 Inection, Chlorpheniramine Injection IP, Triflupromazine Hydrochloride Injection IP, Triamcinolone Acctonide Injection IP, Triamcinolone Acetonide IP and Tetracyclin-bolus Tablets. The Companyâs educational supplements include Demo-Dose Dyaz, Demo-dose colac, Demo-Dose Dilat and Demo-Eose eryth.
Sector
Pharmaceuticals
Calendar
12/08/2024
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -28.82% | 1.34M | |
| +18.04% | 42.95B | |
| +16.92% | 21.38B | |
| +18.33% | 15.05B | |
| +19.27% | 14.45B | |
| +56.12% | 13.04B | |
| -10.73% | 6.72B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +7.31% | 4.84B |
- Stock Market
- Equities
- KAMRLAB Stock
